About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD2.67
- USD2.74
- USD2.50
- USD7.85
- 2.40%
- --
- 1.37M
- 1.78M
- 283M
- 1.29
- -52.80%
Stock News
39 minutes ago
Why Nvidia and these other chip stocks could be standouts this earnings season
MarketWatch
54 minutes ago
Jim Cramer makes the case for why Apple and investors should stick with CEO Tim Cook
CNBC
1 hour ago
Port of Los Angeles sees record container traffic as shippers race to beat Trump's tariff deadlines
CNBC
1 hour ago
The House will vote on a bill to regulate stablecoins during 'Crypto Week'—what it could mean for you
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
